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ABSTRACT
Conclusion: Hence, IHC is an essential adjunct to morphology in diagnosing renal neoplasms.
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INTRODUCTION
Clear cell renal cell carcinomas are the most common type of renal 
carcinomas with a peak incidence in the sixth–seventh decade [1]. They 
show a male preponderance. They generally carry a worse prognosis 
as compared to the other types [2]. The eosinophilic variant has the 
same molecular characteristics as the conventional clear cell renal cell 
carcinoma [3]. The eosinophilic variant differs from the conventional type 
in having cells with abundant eosinophilic cytoplasm. The diagnosis of this 
entity is challenging since it may mimic other eosinophilic neoplasms of 
the kidney. In such cases, immunohistochemistry (IHC) plays a pivotal role 
in arriving at the diagnosis. The importance of recognizing this variant is 
that these tumors are more aggressive and are associated with a higher 
grade, stage, and a poor prognosis. Eosinophilic component greater than 
50% may predict a poor response to interleukin 2 therapy [4].
CASE REPORT
A 75-year-old male patient presented with pain abdomen for 15 days. The 
magnetic resonance imaging of the abdomen showed a mass in the kidney. 
The differential diagnosis given on radiology was renal cell carcinoma 
and hydatid cyst. Nephrectomy was done and the specimen was sent 
for histopathological examination. The specimen measured 21 cm× 
11.5 cm×10 cm. Cut surface showed an ill circumscribed solid cystic gray-
brown lesion with extensive areas of hemorrhage and necrosis located at 
the upper pole of the kidney measuring 15 cm×10.5 cm×7 cm. Adjacent 
area showed normal renal parenchyma. Attached ureter and vessels were 
identified. Sections were submitted as per the protocol for malignant 
tumors. Sections from the lesion showed sheets of cyst macrophages, mixed 
inflammatory infiltrate, cholesterol clefts, numerous multinucleated giant 
cells, hemosiderin-laden macrophages, and extensive areas of hemorrhage 
and necrosis (Fig. 1). Few tissue fragments showed cells arranged in nests, 
acinar pattern, and alveolar clusters. The cells were round to polygonal 
with abundant eosinophilic granular cytoplasm having moderate-sized 
round to oval nucleus with some showing inconspicuous basophilic 
nucleoli (Fig. 2). The nests of cells were surrounded by delicate blood 
vessels. On morphology, the differential diagnosis included oncocytoma 
with extensive inflammation and eosinophilic variant of chromophobe 
renal cell carcinoma. Hale’s colloidal iron was negative, which favored a 
diagnosis of oncocytoma with concurrent inflammation (Fig. 3). However, 
a panel of IHC was requested to confirm the diagnosis. The IHC report 
proved both the differential diagnoses to be wrong. The tumor cells 
were Vimentin, CD 10 positive, and CK 7, CD 117, and S 100 negative 
(Figs. 4-6). This favored the diagnosis of clear cell carcinoma-eosinophilic 
variant. Following this, extensive sampling of the tumor was done. One 
focus of cells having conventional clear cell carcinoma morphology was 
identified (Fig. 7).
DISCUSSION
The prognosis of each type of renal cell carcinoma varies [5]. Hence, it is 
important to classify these tumors. Earlier the diagnosis was solely based 
on morphology. With the advent of IHC, its role in diagnosing tumors 
cannot be overemphasized. IHC plays a pivotal role in the diagnosis of 
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Case Report
Fig. 1: Sheets of cyst macrophages and mixed inflammatory cells 
(Hematoxylin and Eosin, ×100)
A 75-year-old patient presented with pain abdomen. The magnetic resonance imaging showed a mass in the kidney. The differential diagnosis 
given was renal cell carcinoma and hydatid cyst. Nephrectomy was done and the specimen was sent for histopathology. The specimen 
showed a gray-brown lesion with extensive areas of hemorrhage and necrosis. On microscopy, the tumor cells were arranged in nests. The cells 
had abundant eosinophilic granular cytoplasm. The differential diagnosis on morphology was chromophobe renal cell carcinoma and oncocytoma
 with extensive inflammation. However, immunohistochemistry (IHC) proved the diagnosis of eosinophilic variant of clear cell renal cell carcinoma.
Case Report: Eosinophilic variant of clear cell renal cell carcinoma is an important entity to diagnose since it is aggressive and is 
associated with poor prognosis.
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renal carcinomas. Although the morphology hints toward the diagnosis, 
IHC is essential for confirming the same. In our case too, on morphology 
oncocytoma and chromophobe type were considered since these 
tumors commonly have abundant eosinophilic cytoplasm. However, it 
was the IHC which proved that the diagnosis was a clear cell carcinoma. 
Eosinophilic variant of clear cell carcinoma previously called granular 
variant of clear cell carcinoma is a rare tumor which can be confused 
with other eosinophilic neoplasms of the kidney. Chromophobe renal cell 
carcinoma, oncocytoma, and eosinophilic variant of clear cell carcinoma 
always pose a diagnostic challenge. CD 10 and CD 117 are useful markers 
to help in distinguishing the above. CD 10 favors eosinophilic variant 
of clear cell carcinoma and CD 117 favors the other two. The negative 
Fig. 2: Tumor cells having abundant eosinophilic cytoplasm 
(Hematoxylin and Eosin, ×100)
Fig. 3: Tumor cells are colloidal iron negative (Colloidal iron, ×400)
Fig. 4: Tumor cells are CD10 positive (CD10, ×100)
Fig. 5: Tumor cells are vimentin positive (vimentin, ×100)
Fig. 6: Tumor cells are CD117 negative (CD117, ×100)
Fig. 7: Tumor cells showing the conventional clear cell 
morphology (Hematoxylin and Eosin, ×400)
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colloidal iron staining serves as a useful adjunct in diagnosis [6]. The 
eosinophilic variant is usually large on gross morphology with extensive 
areas of hemorrhage and necrosis [7]. Microscopically, the characteristic 
feature is the rich sinusoidal network around the nests of tumor cells [8]. 
This probably serves as a subtle clue to help in arriving at a diagnosis. 
The prognosis of this tumor is poor as compared to the conventional 
clear cell carcinoma. Hence, it is essential to identify this variant. The 
histological features in renal cell carcinoma have an impact on survival 
of the patient [9]. It is said that extensive sampling of the tumor may 
show foci of tumor having the conventional clear cell morphology, as in 
our case [10]. Cancers have now become a serious threat causing death 
in most countries [11]. They are a heterogeneous group, each having 
a varied response to treatment [12]. Importance lies in adequately 
subtyping a tumor to ensure responsiveness to therapy.
CONCLUSION
IHC is an important adjunct to morphology in classifying renal cell 
carcinomas. It is advisable to support the histopathological report with 
IHC to confirm the diagnosis. Since the prognosis of each type of renal 
cell carcinoma varies, it is vital to subtype these tumors and identify 
even the uncommon variants. The eosinophilic variant of clear cell 
carcinomas should be a differential diagnosis in addition to oncocytoma 
and chromophobe renal cell carcinomas in tumors having cells with 
abundant eosinophilic cytoplasm.
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